In focus · trending topic

Biotechnology

2095 stories · following the connections

BioCryst to Present at the Jefferies 2017 Global Healthcare Conference

By Nasdaq OMXMay 31, 2017, 10:01 AM UTC

ProLynx issued US patent for cleavable linker technology on hydrogels

By Nasdaq OMXMay 31, 2017, 12:03 AM UTC

Abeona Therapeutics Receives Rare Pediatric Disease Designation for EB-101 Gene Therapy Product for Patients with Epidermolysis Bullosa

By Nasdaq OMXMay 30, 2017, 12:32 PM UTC

Abeona Therapeutics Receives Rare Pediatric Disease Designation for EB-101 Gene Therapy Product for Patients with Epidermolysis Bullosa

By Nasdaq OMXMay 30, 2017, 12:32 PM UTC

Abeona Therapeutics Receives Rare Pediatric Disease Designation for EB-101 Gene Therapy Product for Patients with Epidermolysis Bullosa

By Nasdaq OMXMay 30, 2017, 12:32 PM UTC

Abeona Therapeutics Receives Rare Pediatric Disease Designation for EB-101 Gene Therapy Product for Patients with Epidermolysis Bullosa

By Nasdaq OMXMay 30, 2017, 12:32 PM UTC

Abeona Therapeutics Receives Rare Pediatric Disease Designation for EB-101 Gene Therapy Product for Patients with Epidermolysis Bullosa

By Nasdaq OMXMay 30, 2017, 12:32 PM UTC

Abeona Therapeutics Receives Rare Pediatric Disease Designation for EB-101 Gene Therapy Product for Patients with Epidermolysis Bullosa

By Nasdaq OMXMay 30, 2017, 12:32 PM UTC